Blog
Gretchen Bowker, Pearl’s COO guest lecturers at Purdue University
On August 2, 2011, Gretchen Bowker will be lecturing at Purdue's school of Biomedical Engineering in a class on Preclinical and Clinical Study Design. Her topic will be "Protecting the rights, welfare, and safety of the patients enrolled in a clinical study" and she...
Save the date October 23-26 for the RAPS annual conference
This year we are thrilled that the annual RAPS conference will be held right here in our home town of Indianapolis. To see all the details and register, check out their website: http://www.raps.org/2011raps. Pearl will be exhibiting, speaking, and leading the way...
Gretchen Miller Bowker, COO of Pearl IRB, speaks at the June 27th SOCRA meeting
Join us at an event hosted by The Society of Clinical Research Associates on June 27th. Gretchen Bowker, COO of Pearl IRB, will be presenting "IND vs. IDE, Likeness and Difference." Date: Monday, June 27, 2011 Time: 5:30 PM - 7:30 PM - Eastern Time Location: Farm...
FDA Releases Draft Guidance Concerning Regulatory Issues Surrounding Nanotechnology
A recent article on Medical News Today's website entitled “FDA Takes 'First Step' Toward Greater Regulatory Certainty Around Nanotechnology” reviews FDA's June 9th release of a draft guidance that provides regulated industries with greater certainty about the use of...
Exception from Informed Consent Requirements for Emergency Research
"In March 2011 FDA finalized guidance on exception of informed consent requirements for emergency research..." To see our COO's full guest blog entry, click here.